Recommendations from the Brazilian society of rheumatology for the diagnosis of Sjogren's syndrome (Part I): glandular manifestations (systematic review)

Carregando...
Imagem de Miniatura
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
TREVISANI, Virginia Fernandes Moca
FERNANDES, Marilena Leal Mesquita Silvestre
LOPSE, Maria Lucia Lemos
FIALHO, Sonia Cristina de Magalhaes Souza
PINHEIRO, Aysa Cesar
SANTOS, Laura Caldas dos
APPENZELLER, Simone
FIDELIX, Tania
RIBEIRO, Sandra Lucia Euzebio
Citação
ADVANCES IN RHEUMATOLOGY, v.59, n.1, article ID 58, 17p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Primary Sjogren's syndrome (pSS) is a systemic immune-mediated disease whose main characteristic is exocrine gland inflammation and, subsequent reduction in tear and saliva production. A delayed diagnosis is common due to the nonspecific clinical manifestations of disease. The aim of the present study was to develop recommendations for the diagnosis of glandular manifestations of pSS based on evidence and expert opinion. Main body of the abstract We conducted a systematic literature review to retrieve the best evidence available on the accuracy of diagnostic tests for pSS. We also held two in-person meetings with experts (rheumatologists, pathologists, ophthalmologists and dentists) to establish their level of agreement using the Delphi method. Ultimately, we generated 18 recommendations that aim to facilitate the diagnosis of the glandular manifestations of pSS. Conclusion The diagnosis of glandular manifestations of pSS is complex and multidisciplinary. It requires specific knowledge in the field of ophthalmology, immunology, pathology and imaging, making it compulsory for the rheumatologist to work with professionals from these different areas in order to improve accuracy and early diagnosis. Glandular dysfunction tests, ANA, RF, Anti-Ro, protein electrophoresis, urinalysis, blood count, C-Reactive protein, complement, testing for syphilis and viruses (HCV, HIV) and SGUS should be investigated when dryness or systemic manifestation are present. Minor salivary gland biopsy is recommended for all anti-Ro negative or incomplete criteria cases.
Palavras-chave
Sjogren's syndrome, Xerostomia, Xerophthalmia, Salivary gland diseases, Lacrimal apparatus diseases, Diagnosis, Practice guideline
Referências
  1. Adatia FA, 2004, CAN J OPHTHALMOL, V39, P767, DOI 10.1016/S0008-4182(04)80071-1
  2. Aggarwal A, 2014, BEST PRACT RES CL RH, V28, P907, DOI 10.1016/j.berh.2015.04.010
  3. Agmon-Levin N, 2017, CLIN EXP RHEUMATOL, V35, P929
  4. ALEXANDER EL, 1994, NEUROLOGY, V44, P899, DOI 10.1212/WNL.44.5.899
  5. Baer AN, 2015, ANN RHEUM DIS, V74, P1557, DOI 10.1136/annrheumdis-2014-206683
  6. Baldini C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0657-7
  7. Baldini C, 2012, J AUTOIMMUN, V39, P9, DOI 10.1016/j.jaut.2011.12.006
  8. Barone F, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14168
  9. Billings M, 2016, EBIOMEDICINE, V12, P270, DOI 10.1016/j.ebiom.2016.09.005
  10. Bloch DB, 2017, ANTI RO SSA ANTI LA
  11. Bookman AAM, 2011, ARTHRITIS RHEUM-US, V63, P2014, DOI 10.1002/art.30295
  12. Bowman SJ, 2003, J RHEUMATOL, V30, P1259
  13. Brito-Zeron P, 2018, CLIN EXP RHEUMATOL, V36, pS102
  14. Brito-Zeron P, 2016, EXPERT REV CLIN IMMU, V12, P137, DOI 10.1586/1744666X.2016.1109449
  15. Caffery B, 2010, INVEST OPHTH VIS SCI, V51, P2381, DOI 10.1167/iovs.09-4188
  16. Camp A, 2015, CONTACT LENS ANTERIO, V38, P220, DOI 10.1016/j.clae.2015.02.001
  17. Campos J, 2016, RHEUM DIS CLIN N AM, V42, P473, DOI 10.1016/j.rdc.2016.03.006
  18. CHISHOLM DM, 1968, J CLIN PATHOL, V21, P656, DOI 10.1136/jcp.21.5.656
  19. Cockrell D J, 1993, Dentomaxillofac Radiol, V22, P41
  20. Barboza MNC, 2008, ARQ BRAS OFTALMOL, V71, P547, DOI 10.1590/S0004-27492008000400015
  21. Cornec D, 2014, RHEUMATOLOGY, V53, P1604, DOI 10.1093/rheumatology/keu037
  22. Cornec D, 2013, ARTHRITIS RHEUM-US, V65, P216, DOI [10.1002/art.37698, 10.1002/art.37944]
  23. DANIELS TE, 1975, ORAL SURG ORAL MED O, V39, P875, DOI 10.1016/0030-4220(75)90108-5
  24. Daniels TE, 2011, ARTHRITIS RHEUM-US, V63, P2021, DOI 10.1002/art.30381
  25. Delli K, 2015, ORAL DIS, V21, P792, DOI 10.1111/odi.12349
  26. DEVITA S, 1992, CLIN EXP RHEUMATOL, V10, P351
  27. Falcao DP, 2013, REV BRAS REUMATOL, V53, P525, DOI [10.1016/j.rbr.2013.03.001, 10.1016/j.rbre.2013.03.001]
  28. Fayyaz A, 2016, RHEUM DIS CLIN N AM, V42, P419, DOI 10.1016/j.rdc.2016.03.002
  29. Fidelix T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182287
  30. Fisher BA, 2017, ANN RHEUM DIS, V76, P1161, DOI 10.1136/annrheumdis-2016-210448
  31. Foulks Gary N, 2003, Ocul Surf, V1, P20
  32. Franceschini F, 2005, AUTOIMMUNITY, V38, P55, DOI 10.1080/08916930400022954
  33. Giovelli RA, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0482-9
  34. GREENSPAN JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4
  35. Guellec D, 2013, AUTOIMMUN REV, V12, P416, DOI 10.1016/j.autrev.2012.08.001
  36. Haacke EA, 2018, ANN RHEUM DIS, V77, pE32, DOI 10.1136/annrheumdis-2017-212164
  37. Hammenfors DS, 2015, CLIN EXP RHEUMATOL, V33, P56
  38. HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207
  39. Higgins JP, 2011, COCHRANE COLLABORATI, DOI 10.1002/9780470712184
  40. Hocevar A, 2005, RHEUMATOLOGY, V44, P768, DOI 10.1093/rheumatology/keh588
  41. Jonsson MV, 2008, J ORAL PATHOL MED, V37, P515, DOI 10.1111/j.1600-0714.2008.00674.x
  42. Jousse-Joulin S, 2019, ANN RHEUM DIS, V78, P967, DOI 10.1136/annrheumdis-2019-215024
  43. Jousse-Joulin S, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000364
  44. Jousse-Joulin S, 2016, RHEUMATOLOGY, V55, P789, DOI 10.1093/rheumatology/kev385
  45. Kalk WWI, 2002, ORAL SURG ORAL MED O, V94, P131, DOI 10.1067/moe.2002.126017
  46. Kojima I, 2017, ORAL DIS, V23, P84, DOI 10.1111/odi.12577
  47. Le Goff M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1475-x
  48. Lee AYS, 2017, RHEUMATOL INT, V37, P1323, DOI 10.1007/s00296-017-3718-1
  49. Lomas DJ, 1996, RADIOLOGY, V200, P129, DOI 10.1148/radiology.200.1.8657900
  50. MENGHER LS, 1986, ACTA OPHTHALMOL, V64, P441
  51. Menor A. R., 2016, REUMATOL CLIN, V12, P256, DOI 10.1016/J.REUMA.2015.10.010
  52. Milic VD, 2010, SCAND J RHEUMATOL, V39, P160, DOI 10.3109/03009740903270623
  53. Milic V, 2012, RHEUMATOLOGY, V51, P1081, DOI 10.1093/rheumatology/ker431
  54. Milic VD, 2009, J RHEUMATOL, V36, P1495, DOI 10.3899/jrheum.081267
  55. MOUTSOPOULOS HM, 1980, ANN INTERN MED, V92, P212, DOI 10.7326/0003-4819-92-2-212
  56. Niemela RK, 2004, RHEUMATOLOGY, V43, P875, DOI 10.1093/rheumatology/keh187
  57. Obinata K, 2010, ORAL SURG ORAL MED O, V109, P129, DOI 10.1016/j.tripleo.2009.08.033
  58. Oden NL, 1998, ADV EXP MED BIOL, V438, P807
  59. Ohbayashi N, 1998, RADIOLOGY, V209, P683, DOI 10.1148/radiology.209.3.9844659
  60. PENNEC YL, 1993, CLIN EXP RHEUMATOL, V11, P523
  61. Poul JHK, 2008, DENTOMAXILLOFAC RAD, V37, P392, DOI 10.1259/dmfr/50668408
  62. Ramos-Casals M, 2010, J RHEUMATOL, V37, P585, DOI 10.3899/jrheum.090835
  63. Rischmueller M, 2016, BEST PRACT RES CL RH, V30, P189, DOI 10.1016/j.berh.2016.04.003
  64. Risselada AP, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2014-207150
  65. Risselada AP, 2014, ANN RHEUM DIS, V73, P1537, DOI 10.1136/annrheumdis-2013-204634
  66. Rivera TL, 2009, ANN RHEUM DIS, V68, P828, DOI 10.1136/ard.2008.088054
  67. Rose-Nussbaumer J, 2015, AM J OPHTHALMOL, V160, P1150, DOI 10.1016/j.ajo.2015.08.021
  68. Routsias JG, 2007, CLIN REV ALLERG IMMU, V32, P238, DOI 10.1007/s12016-007-8003-8
  69. RUBIN P, 1957, AMER J ROENTGENOL RA, V77, P575
  70. Salaffi F, 2008, RHEUMATOLOGY, V47, P1244, DOI 10.1093/rheumatology/ken222
  71. Salerno S, 2002, DENTOMAXILLOFAC RAD, V31, P154, DOI 10.1038/sj.dmfr.4600671
  72. SCHALL GL, 1971, J AMER MED ASSOC, V216, P2109, DOI 10.1001/jama.216.13.2109
  73. Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615
  74. Scully C, 2012, SJOGRENS SYNDROME DI, P85
  75. Sene D, 2018, ARTHRITIS RHEUMATOL, V70, P1481, DOI 10.1002/art.40528
  76. Seror R, 2013, ARTHRIT CARE RES, V65, P1358, DOI 10.1002/acr.21991
  77. Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI 10.1136/annrheumdis-2016-210571
  78. Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591
  79. Takagi Y, 2014, RHEUMATOLOGY, V53, P1977, DOI 10.1093/rheumatology/keu238
  80. Takagi Y, 2010, ANN RHEUM DIS, V69, P1321, DOI 10.1136/ard.2009.123836
  81. Theander E, 2015, ARTHRITIS RHEUMATOL, V67, P2427, DOI 10.1002/art.39214
  82. Theander E, 2014, ARTHRIT CARE RES, V66, P1102, DOI 10.1002/acr.22264
  83. Theander E, 2011, ANN RHEUM DIS, V70, P1363, DOI 10.1136/ard.2010.144782
  84. Tonami H, 2001, J COMPUT ASSIST TOMO, V25, P262, DOI 10.1097/00004728-200103000-00020
  85. Valim V, 2017, FUNDAMENTOS ULTRASSO
  86. Valim V, 2015, CLIN REV ALLERG IMMU, V49, P288, DOI 10.1007/s12016-014-8438-7
  87. VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10
  88. Varela-Centelles P, 2014, MED ORAL PATOL ORAL, V19, pE20, DOI 10.4317/medoral.19131
  89. Versura P, 2007, EYE, V21, P229, DOI 10.1038/sj.eye.6702204
  90. VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309
  91. Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
  92. VITALI C, 1994, ANN RHEUM DIS, V53, P637, DOI 10.1136/ard.53.10.637
  93. Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013
  94. Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
  95. Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001
  96. Yonetsu K, 2002, ANN RHEUM DIS, V61, P276, DOI 10.1136/ard.61.3.276
  97. Yoshiura K, 1997, ORAL SURG ORAL MED O, V83, P400, DOI 10.1016/S1079-2104(97)90249-3
  98. Yu Chuang-qi, 2007, Shanghai Kou Qiang Yi Xue, V16, P247
  99. Zeev MSB, 2014, CLIN OPHTHALMOL, V8, P581, DOI 10.2147/OPTH.S45444